Progress of aspirin in endometrial neoplasms
10.3760/cma.j.issn.1006-9801.2018.10.018
- VernacularTitle:阿司匹林在子宫内膜癌中的研究进展
- Author:
Wen WANG
1
,
2
;
Shiqian ZHANG
Author Information
1. 277599 山东省滕州市中心人民医院妇产科
2. 250012 济南,山东大学齐鲁医院妇产科
- Keywords:
Endometrial neoplasms;
Aspirin;
Non-steroidal anti-inflammatory drugs
- From:
Cancer Research and Clinic
2018;30(10):713-716
- CountryChina
- Language:Chinese
-
Abstract:
Obesity and exogenous hormone exposure are the well-established endometrial cancer risk factors, which are associated with chronic inflammation. Some evidences have shown that inflammation is potentially related to the increased risk of endometrial neoplasms. Aspirin is one of the most studied non-steroidal anti-inflammatory drugs, which can benefit the endometrial cancer patients with obesity. Although aspirin-related bleeding has to be considered prior to therapy, in most cases, the benefits of low-dose aspirin therapy substantially will exceed the risk. Aspirin and other non-steroidal anti-inflammatory drugs are expected to become effective new methods for the treatment of the tumors. This paper reviews the progress of aspirin in endometrial neoplasms.
